Bronte Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-74,920	Closed	-$3.26M	–	28
2021 Q3	$3.26M	Buy	+74,920	New	+$3.26M	0.24%	19